# Prospective Study to Assess the Safety and Performance of the Easyx Antia Liquid Embolic in Intracranial Interventions

> **NCT02863133** · NA · UNKNOWN · sponsor: **Antia Therapeutics AG** · enrollment: 65 (estimated)

## Conditions studied

- Arterial Embolization

## Interventions

- **DEVICE:** Liquid Embolic

## Key facts

- **NCT ID:** NCT02863133
- **Lead sponsor:** Antia Therapeutics AG
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-10
- **Primary completion:** 2017-10
- **Final completion:** 2018-10
- **Target enrollment:** 65 (ESTIMATED)
- **Last updated:** 2016-08-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02863133

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02863133, "Prospective Study to Assess the Safety and Performance of the Easyx Antia Liquid Embolic in Intracranial Interventions". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT02863133. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*